Veracity Capital LLC Novartis Ag Transaction History

Veracity Capital LLC

$303 Million
Q3 2025

A detailed history of Veracity Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Veracity Capital LLC holds 3,766 shares of NVS stock, worth $495,417. This represents 0.16% of its overall portfolio holdings.

Number of Shares

3,766

Previous 3,707 1.59%

Holding current value

$495,417

Previous $448,000 7.59%

% of portfolio

0.16%

Previous 0.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	BUY	$113.5 - $129.73 $6,696 - $7,654	59 Added 1.59%	3,766 $482,000
Q2 2025 Jul 09, 2025	BUY	$101.96 - $121.01 $6,219 - $7,381	61 Added 1.67%	3,707 $448,000
Q1 2025 Apr 10, 2025	SELL	$97.14 - $115.57 $17,679 - $21,033	-182 Reduced 4.75%	3,646 $406,000
Q4 2024 Jan 17, 2025	SELL	$96.78 - $117.18 $12,774 - $15,467	-132 Reduced 3.33%	3,828 $372,000
Q3 2024 Oct 18, 2024	BUY	$106.13 - $120.89 $75,989 - $86,557	716 Added 22.07%	3,960 $455,000

Q2 2024 Jul 22, 2024	SELL	$92.57 - $107.37 $20,735 - $24,050	-224 Reduced 6.46%	3,244 $345,000
Q1 2024 Apr 19, 2024	BUY	$95.27 - $108.47 $4,858 - $5,531	51 Added 1.49%	3,468 $335,000
Q4 2023 Jan 22, 2024	BUY	$92.27 - $101.54 $738 - $812	8 Added 0.23%	3,417 $345,000
Q3 2023 Oct 25, 2023	BUY	$94.73 - $105.13 $568 - $630	6 Added 0.18%	3,409 $347,000
Q2 2023 Jul 20, 2023	SELL	$92.52 - $104.91 $92 - $104	-1 Reduced 0.03%	3,403 $343,000
Q1 2023 Apr 06, 2023	SELL	$80.03 - $92.81 $1,440 - $1,670	-18 Reduced 0.53%	3,404 $313,000
Q4 2022 Jan 17, 2023	SELL	$75.55 - $92.52 $75 - $92	-1 Reduced 0.03%	3,422 $0
Q3 2022 Oct 17, 2022	SELL	$74.61 - $87.26 $8,729 - $10,209	-117 Reduced 3.31%	3,423 $260,000
Q2 2022 Jul 18, 2022	SELL	$80.52 - $93.75 $2,013 - $2,343	-25 Reduced 0.7%	3,540 $299,000
Q1 2022 Apr 18, 2022	BUY	$80.11 - $90.62 $8,331 - $9,424	104 Added 3.0%	3,565 $313,000
Q4 2021 Jan 31, 2022	BUY	$79.7 - $88.13 $1,195 - $1,321	15 Added 0.44%	3,461 $303,000
Q3 2021 Oct 13, 2021	BUY	$81.78 - $95.14 $1,553 - $1,807	19 Added 0.55%	3,446 $282,000
Q2 2021 Jul 22, 2021	SELL	$85.24 - $94.15 $14,405 - $15,911	-169 Reduced 4.7%	3,427 $313,000
Q1 2021 Apr 12, 2021	BUY	$83.5 - $98.47 $3,507 - $4,135	42 Added 1.18%	3,596 $307,000
Q4 2020 Jan 25, 2021	SELL	$78.07 - $94.43 $40,440 - $48,914	-518 Reduced 12.72%	3,554 $336,000
Q3 2020 Oct 21, 2020	SELL	$82.14 - $91.0 $13,224 - $14,651	-161 Reduced 3.8%	4,072 $354,000
Q2 2020 Jul 13, 2020	SELL	$80.93 - $91.1 $398,499 - $448,576	-4,924 Reduced 53.77%	4,233 $370,000
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $24,027 - $33,663	-340 Reduced 3.58%	9,157 $755,000
Q4 2019 May 07, 2020	BUY	$84.35 - $95.37 $801,071 - $905,728	9,497 New	9,497 $899,000

Others Institutions Holding NVS

# of Institutions

1,610

Shares Held

137M

Call Options Held

1.53M

Put Options Held

2.22M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $283B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veracity Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veracity Capital LLC with notifications on news.

Account

Veracity Capital LLC Novartis Ag Transaction History